loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Raloxifene Hydrochloride to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 Gangwal Healthcare (5)

02 Nanjing Well Pharmaceutical (4)

03 Actylis (2)

04 Aeon Procare (2)

05 BASF (15)

06 Finar (4)

07 Ideal Cures Pvt Ltd (2)

08 Kerry (14)

09 Kima Chemical (1)

10 Lonza Capsugel (1)

11 Nomisma Healthcare (2)

12 Sigachi Industries (1)

13 The Dow Chemical Company (2)

filter

01 Capsule (10)

02 Cream / Lotion / Ointment (3)

03 Gel (3)

04 Granule / Pellet (2)

05 Injectable / Parenteral (1)

06 Softgels (1)

07 Solution (1)

08 Tablet (27)

09 Topical Film (2)

10 Transdermal Patch (4)

11 Transdermal patches (1)

filter

01 China (5)

02 Germany (15)

03 India (16)

04 U.S.A (19)

Close
4

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide, Polyethylene Glycol Excipient

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

TALC

URL Supplier Web Content
LM Application #LearnMore

Applications:

Talc is a widely used as a dissolution retardant in the development of controlled release products. Talc is also used as a lubricant in tablet formulations.

Ingredient(s): Talc Excipient

Dosage Form: Granule / Pellet, Tablet

Category: Controlled & Modified Release, Lubricants & Glidants

Route of Administration (Grade): Oral & Topical
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content